Pascal Soriot's most recent trade in Astrazeneca plc was a trade of 101,495 Ords 0.25p done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 05 Mar 2026 | 101,495 | 352,069 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 04 Mar 2026 | 14,967 | 250,574 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 07 Nov 2025 | 136,537 | 522,935 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 07 Nov 2025 | 136,537 | 386,398 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 21 May 2025 | 8,970 | 386,398 (0%) | 0% | 0 | Ords 0.25p | ||
| Agilent Tech | Pascal Soriot | Director | Grant, award, or other acquisition of securities at price $ 108.91 per share. | 21 May 2025 | 1,677 | 1,677 (0%) | 0% | 108.9 | 182,642 | Common Stock |
| Agilent Tech | Pascal Soriot | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.91 per share. | 21 May 2025 | 504 | 1,173 (0%) | 0% | 108.9 | 54,891 | Common Stock |
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 06 Mar 2025 | 89,962 | 377,428 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Mar 2025 | 248 | 287,466 (0%) | 0% | 0 | Ords 0.25p | |
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 04 Mar 2025 | 17,357 | 287,218 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 102.03 per share. | 14 Nov 2024 | 20,000 | 221,356 (0%) | 0% | 102.0 | 2,040,600 | Ords 0.25p |
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 10 Jun 2024 | 297,418 | 201,356 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 08 Mar 2024 | 105,238 | 498,774 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 05 Mar 2024 | 17,702 | 393,536 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Soriot Pascal | Executive Director,Chief Executive Officer | 20 Feb 2024 | 12,345 | 375,834 (0%) | 0% | 0 | Ords 0.25p |